Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07367568

Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy

Comparison of Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
National Cancer Institute, Egypt · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.

Detailed description

Postoperative pain following modified radical mastectomy (MRM) is a considerable consequence, impacting the ipsilateral upper limbs, axillae, and thorax, resulting in diminished functional ability and substantial economic and societal repercussions. Erector spinae plane block (ESPB), an interfascial block, minimizes nerve and vessel injury by allowing local anesthetics to diffuse across relevant spaces; it is technically simpler and has shown benefits in reducing postoperative analgesic use and pain scores. A novel technique, the costotransverse foramen block (CTFB), is one type of Inter-transverse process (ITP) blocks. This technique entails the anterior dispersion of the local anesthetic injectate into the paravertebral region, affecting the thoracic nerve at the injection site and neighboring levels, while exhibiting negligible posterior diffusion of dye to the deep back muscles

Conditions

Interventions

TypeNameDescription
OTHERCostotransverse foramen blockPatients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.
OTHERErector spinae plane blockPatients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%.

Timeline

Start date
2026-01-24
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2026-01-26
Last updated
2026-01-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07367568. Inclusion in this directory is not an endorsement.